Jasper Therapeutics
JSPR
JSPR
55 hedge funds and large institutions have $35.2M invested in Jasper Therapeutics in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
55.32% less ownership
Funds ownership: 124.01% → 68.69% (-55%)
Holders
55
Holding in Top 10
2
Calls
$449K
Puts
$67K
Top Buyers
| 1 | +$3.45M | |
| 2 | +$2.37M | |
| 3 | +$1.42M | |
| 4 |
ACA
Acorn Capital Advisors
New York
|
+$811K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$705K |
Top Sellers
| 1 | -$3.15M | |
| 2 | -$2.6M | |
| 3 | -$2.45M | |
| 4 |
SAM
Simplify Asset Management
Las Vegas,
Nevada
|
-$1.45M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.18M |
